Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimizing Infection Prophylaxis Prior to Shoulder Surgery
NCT06464770Recruiting
- Sponsor
- University of Washington
- Start
- Aug 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of chlorhexidine + alcohol in periprosthetic joint infection (PJI) (2 arms), sponsored by University of Washington. Primary endpoints: Number of Quadrants on Culture Plate of Cutibacterium Growth After ChloraPrep Application with Dermal Pressure at 60 months and Number of Quadrants on Culture Plate of Cutibacterium Growth After ChloraPrep Application with Subdermal Pressure at 60 months. Started Aug 2024; status: recruiting.
02
Drugs
chlorhexidine + alcohol
03
Conditions
periprosthetic joint infection (PJI)
Beyond the preview
Go deeper on NCT06464770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06464770.